NKX3.1 is a homeobox gene required for prostate tumor progression and was implicated in androgen-dependent prostate cancer survival33, while RHOU was implicated in epidermal growth factor receptor signaling and cell migration34. This evidence concerns the gene RHOU and prostate cancer.